To speed the drug discovery path, San Diego’s Sanford Burnham Prebys Medical Discovery Institute, or SBP, recently partnered with WARF Therapeutics.
WARF Therapeutics, an arm of the Wisconsin Alumni Research Foundation, enlisted SBP to help with its mission of investing in promising drug targets.
Under the five-year deal, SBP, WARF and University of Wisconsin-Madison scientists plan to translate drug targets into early-drug discovery. That includes hunting for chemical compounds that could lead to prototype drugs, drawing on Sanford’s compound library.
Financial terms of the deal were not disclosed.
SBP employs almost 800 scientists and staff in La Jolla. It has a NCI-designated Cancer Center, the Conrad Prebys Center for Chemical Genomics and the Sanford Children’s Health Research Center.
SBP holds a similar partnership with the Mayo Clinic, struck in 2012 to build a pipeline of drugs for unmet diseases.
